Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus alfentanil for painless gastrointestinal endoscopy
ChiCTR2100046745Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil and propofol (4 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Incidence of intraoperative blood pressure reduction. Started Jun 2021; status: recruiting.
02
Drugs
remimazolamalfentanilpropofol
Beyond the preview
Go deeper on ChiCTR2100046745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046745.